Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Meghann Klowak"'
Autor:
Andrew Gomori, Meghann Klowak, Michael Prout, Farid Esfahani, Michael Namaka, Romeo Hizon, Amy Grossberndt, Christine Leong, Michael R. Mulvey, Loressa Klassen, Maria Melanson, Malcolm Doupe, Aneri Gupta, Emma E. Frost
Publikováno v:
Multiple Sclerosis Journal. 17:397-403
Background: Staphylococcus aureus may produce superantigens that can non-specifically activate CD4+ cells to potentially target the myelin basic protein. Objective: This study examined the association between individuals with multiple sclerosis (MS)
Autor:
Michael Prout, Michael Namaka, Andrew Gomori, Meghann Klowak, Maria Melanson, Emma E. Frost, Colin R. Gramlich, Lisa Wong, Malcom Doupe, Amy Grossberndt, Christine Leong, Farid Esfahani, Josee-Anne Le Dorze
Publikováno v:
International Journal of Neuroscience. 120:631-640
Fatigue and cognitive deficits are common symptoms affecting patients with multiple sclerosis.The effects of interferon beta on fatigue and cognitive deficits were assessed in 50 patients with relapsing multiple sclerosis (recruited at a single cente
Autor:
Michael Namaka, Howard Intrater, Meghann Klowak, Amy Grossberndt, Christine Leong, Andrew Gomori, Farid Esfahani, Dana Turcotte
Publikováno v:
The Consultant Pharmacist. 24:885-902
OBJECTIVE The purpose of this review is to provide an update of the neuropathic pain treatment algorithm previously published by Namaka et al. in 2004. This algorithm focuses on the strategic incorporation of the latest pain therapies while providing
Autor:
Marcus Vasconcelos, Meghann Klowak, Andrea Doupe, Arla Crook, Maria Melanson, Yuewen Gong, Kulwinder Kler, Mike Namaka, Alicja Wojewnik-Smith
Publikováno v:
Neurological Research. 30:710-719
The purpose of this article is to provide a comprehensive overview of the most frequently encountered non-conventional approaches trialed for use in multiple sclerosis (MS). The efficacy and safety of non-conventional approaches ranging from bee veno
Autor:
Christine Leong, Meghann Klowak, David Eisenstat, Yuewen Gong, Pinhui Miao, Hong Shen, Kim Madec, Xiaochen Gu, Michael Namaka, Maria Melanson
Publikováno v:
Neurological research. 30(6)
Neuropathic pain is a chronic pain syndrome associated with drug, injury or disease-induced damage or destruction of sensory afferent fibers of the dorsal root ganglia (DRG). Although the exact underlying pathologic mechanisms are not known, pro-infl
Autor:
Yuewen Gong, Aneri Gupta, Meghann Klowak, Marcus Vasconcelos, Maria Melanson, Mike Namaka, Merinda Pollitt-Smith, Dana Turcotte
Publikováno v:
Current medical research and opinion. 22(2)
Neutralizing antibodies (NAbs) develop in patients receiving interferon beta (IFN-beta) for multiple sclerosis (MS). Debate continues concerning the relevance of NAb development on treatment efficacy.To determine the incidence and clinical importance
Autor:
Amy Grossberndt, Meghann Klowak, Christine Leong, Emma E. Frost, Dana Turcotte, M.J. Melanson, Michael Prout, L. Vuong, S. Andresen, Mike Namaka, Malcolm Doupe, J-A. Le Dorze
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 2011, Iss 3, Pp 449-458 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Background and purposeMitoxantrone (MX) (Novantrone®) is approved in Canada for certain refractory cancers and acute non-lymphocytic leukemias. It has FDA approval as an immunomodulatory agent for use in secondary progressive multiple sclerosis (SPM
Autor:
Ewa Leligdowicz, Amy Grossberndt, Christine Leong, Jenny Drummond, Mike Namaka, Meghann Klowak, Melanie Lichkowski, Christopher Louizos, Maria Melanson
Publikováno v:
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 142:190-198.e1
Introduction Triptans, ergotamine derivatives and nonsteroidal anti-inflammatory drugs are front-line agents used in the acute abortive therapy of migraines. In this article, these medications are reviewed and a treatment algorithm suggested. Methods